AKYA — Akoya Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual balance sheet for Akoya Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	17	113	81.2	83.1	35
Net Total Accounts Receivable
Net Total Receivables	6.47	9.44	9.73	17	13.8
Total Inventory
Prepaid Expenses
Total Current Assets	28.7	141	112	122	76.7
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	7.02	10	24.5	21.5	14.3
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	77.7	191	176	180	125
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	17.2	27.7	37.1	35.3	29.4
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	59.6	69.6	117	127	117
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	18.1	121	58.6	53.8	7.59
Total Liabilities & Shareholders' Equity	77.7	191	176	180	125
Total Common Shares Outstanding